NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Finnrick
Free Test
← Tirzepatide vendors

Kerui Peptide HongKongTirzepatide

5 testslatest 10 Sept 2026$0.54/mg median
Visit websitekeruihk.comIntelligence report22 pages · who runs this vendorMonitor this vendor24/7 safety alerts · Finnrick Gold
Free peptide testing

Ordered Tirzepatide from Kerui Peptide HongKong? Mail in a sample (US only) and let us test it for free.

Test my supply
+10 more ↓
79%
Finnrick rating
#108 of 202 Tirzepatide vendors
4 of 5 classifiable tests passed
customers 4.4★ (6)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Kerui Peptide HongKong's purity-focus record is narrow but includes intermittent strong Retatrutide results, with recent 99.9% purity passes showing some high-end performance. The same Retatrutide evidence is volatile and failure-heavy, including identity/0 mg results and an 85.9% purity sample, so confidence is constrained by dispersion despite recency.

methodology →
vendor intelligence report
Vendor Intelligence Report: Kerui Peptide HongKong

A live Hong Kong company record is real, but WHOIS, hosting paths, and forum placement point away from a simple Hong Kong operating story. The report maps the Emily-KR/Iris1 sales trail, payment rails, and GLP-1 enforcement exposure.

22 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
18 rated · tap to focus
#
Peptide
$/MG
Rating
N
1
Tirzepatideselected
$0.54
79%
5
2
Retatrutide
$0.64
71%
14
3
Tesamorelin
$1.80
48%
1
4
5-Amino-1MQ
$0.17
-
0
5
BPC-157
$0.66
-
0
6
Cagrilintide
$2.72
-
0
7
CJC-1295
$2.38
-
0
8
Epithalon
-
-
0
9
GHK-Cu
$0.06
-
0
10
GLOW
$0.29
-
0
11
Glutathione
$0.01
-
0
12
Ipamorelin
$0.74
-
0
13
KLOW
$0.23
-
0
14
KPV
$0.54
-
0
15
MOTS-c
$0.53
-
0
16
NAD+
$0.01
-
0
17
Pinealon
-
-
0
18
Sermorelin
-
-
0
Contact channels
5 channels on file
Websitekeruihk.comWhatsApp+85257775735WhatsApp+85255188336WhatsApp+85244048367Emaildzz4689580@gmail.com
Rating trend
Tirzepatide from this vendor, after each test
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%20 May 2026: 80%17 Jun 2026: 81%22 Jul 2026: 82%5 Aug 2026: 83%10 Sept 2026: 79%20 Sept 2026: current 79%80%82%79%May 26Sep 26
Showing Tirzepatide tests only
Kerui Peptide HongKong Tirzepatide test history
5 tests · 4 pass · 1 fail
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
10 Sep 2026Fail
v4ezn9n
Tested
lab nameView COA
5 Aug 2026Pass
gpuxuf5
Tested
lab nameView COA
22 Jul 2026Pass
jvxa573
Tested
lab nameView COA
17 Jun 2026Pass
hfrebvd
Tested
lab nameView COA
20 May 2026Pass
a5fya5m
Tested
lab nameView COA

About Kerui Peptide HongKong test results from Finnrick

Kerui Peptide HongKong is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 20 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Kerui Peptide HongKong peptides in this dataset are Retatrutide (14 tests), Tesamorelin (1 test) and Tirzepatide (5 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 20 recent tests.

Corrections
0 corrections
No corrections.
Free peptide testing

Ordered Tirzepatide from Kerui Peptide HongKong? Mail in a sample (US only) and let us test it for free.

Test my supply